Investing Profile

Sakae Asanuma

InvestorVC

President & CEO at Taiho Ventures

taihoventures.com/team.htmlSan Francisco, California
Photo of Sakae Asanuma, President at Taiho Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Taiho Ventures President
$100K - $5.0M
$1.5M
7
$150M
CompanyStageDateRound SizeTotal Raised
Axial Biotherapeutics
Series COct 2021$37M
Series BJun 2019$10M
$86M
Co-investors: James Blair (Domain Associates)
Anavo Therapeutics
Seed RoundApr 2021€20M
€20M
Co-investors: Therese Liechtenstein (M Ventures (Merck)), Simone Botti (INKEF Capital)
Orna Therapeutics
Series AFeb 2021$80M
$320M
Co-investors: Ansbert Gadicke (MPM Capital), Brian Goodman (MPM Capital), Shinichiro Fuse
Theolytics
Series AJan 2021$6.8M
$6.8M
Co-investors: Therese Liechtenstein (M Ventures (Merck))
Dren Bio
Series AOct 2020$60M
$130M
Co-investors: Andrew Schiff (Aisling Capital)
Storm Therapeutics
Series AJan 2018£4M
£30M
Co-investors: Bruno Montanari (Seroba Life Sciences), Hakan Goker (M Ventures (Merck))